Clinical Trial Update: Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant immuno-oncology trial for primary clear cell renal cell carcinoma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING